Schreiner MediPharm’s Pharma-Comb IL Label Supports Innovative Clinical Cancer Trial with Oncolytic Viruses
Various clinical trials are currently focused on investigating the systematic use of oncolytic viruses in cancer therapies. Shanghai Yuan Song Biotechnology is one of the companies engaged in this research. For its trial relating to innovative virotherapy, Schreiner MediPharm supplies the appropriate specialty label with various integrated functions that easily withstands low temperatures of -20 till -70 degrees Celsius.
Cancer is one of the most frequent causes of death worldwide. In many industrial nations, cancer has even begun to outnumber cardiovascular diseases. Annual investments in cancer research have been increasing accordingly. Virotherapy is a novel approach. It is an immunotherapy in which patients receive injections with oncolytic viruses. These viruses infect tumor cells and can thus selectively destroy malignant cells. The Chinese company Yuan Song Biotechnology is engaged in virotherapy research. However, the active pharmaceutical ingredient (API) for the cancer treatment that is filled in vials is especially sensitive, which poses a challenge also to the label. But the pharmaceutical company has found an ideal solution: the Pharma-Comb IL Label from Schreiner MediPharm.
The sensitive API for cancer therapy from Yuan Song Biotechnology must be stored and transported at low temperatures. The liquid medication is subsequently thawed before being administered. These temperature differences make high demands on the reliable adhesion of the marking and documentation label that is attached to the unit dose vials containing the API. In addition, healthcare staff prior to administering the drug must check if the medication is flawless and the liquid is clear. A transparent inspection window must be integrated into the label for that purpose. At the same time, the label must provide adequate space for important information and contain two removable parts for documenting the administration of the medication in the patient and hospital files for the clinical trial.
Schreiner MediPharm’s customized Pharma-Comb IL Label convinced Yuan Song–especially in terms of the multifunctional combination of additional features and the temperature stability of the material and adhesive. It enables reliable and clear product marking from storage to transportation to dispensing. The two removable documentation labels have tabs enabling easy and efficient peel-off and attachment to the patient files. Thanks to the transparent inspection window, the vial liquid can be reliably checked prior to being administered. Thus, the Pharma-Comb IL Label from Schreiner MediPharm helps optimize clinical trial processes and supports patient safety.